Cancer Research in UK

Imperial Cancer Research Fund (ICRF) has been introduced in 1902 as the Cancer Research Fund and its name was changed to Imperial Cancer Research Fund, two years later. The charity has grown over the next twenty years as one of the leading cancer charity in the world of research. Until the merger, which has made an enormous contribution in almost all research on cancer. Its laboratories in Lincoln & Inn Fields and Clare Hall, now known as Cancer Research UK London Research Institute.

In 2008/09, the charity spent 303 million pounds for Cancer Research, the funding of the work of more than 4,500 scientists, doctors and nurses in the UK. Supports more than 100 clinical trials and cancer research and cancer risk in over one million people in the United Kingdom. Approximately 40% of total expenditure on research is basic research laboratory, which is relevant to all types of cancer. This research on the molecular basis of cancer to better understand how cancer grows and spreads and therefore provides a basis for future research. The remaining funding is used to support research at more than 100 types of specific cancers, focusing on key areas such as drug discovery and development, prevention, early detection and imaging, surgery and radiotherapy, and cancer, where survival is still low, as the esophagus, lung and pancreas. This important work will help ensure that millions of people who survive cancer.